-
GSK's vaccines access leads the pack, report says, as lagging Pfizer disputes findings
fiercepharma
March 08, 2017
For the first time, the public health watchdogs at the Access to Medicine Foundation have trained their microscopes specifically on vaccines and the companies that make them.
-
350 medical and patient groups write to Trump: ‘Vaccines are safe’
fiercepharma
February 15, 2017
Spooked by President Donald Trump’s skeptical stance on vaccines, more than 350 pro-vaccine groups decided to express their “unequivocal support for the safety of vaccines” in a letter to the president.
-
Witty's bet on vaccines pays off in GSK CEO's final full year
fiercepharma
February 13, 2017
After nearly 10 years at the CEO post for GlaxoSmithKline, Andrew Witty is handing over the reins to a company that has been reshaped with a vaccines focus. And during Witty’s final full year at the drugmaker, that business segment outgrew each of GSK’s o
-
Sartorius Stedim Biotech launches two Single-use Sartocon Loop Assemblies with Integrated Polyethers
pharmaasia
February 08, 2017
Assemblies save up to 60 percent on processing time and offer a safe approach to ultrafiltration of biologics and vaccines.
-
Meningococcal vaccines – global drug forecast and market analysis to 2025
pharmaasia
January 16, 2017
GSK will pass Sanofi as the main provider of meningococcal vaccines in the marketplace by 2025.
-
Stellar Biotechnologies advances strategic plan to secure key production region
cphi-online
January 13, 2017
Company aims to increase production capacity to supply multiple commercial-scale therapeutic vaccines under development.
-
Prokarium, Probiomed Initiate Scale-up of Thermostable Vaccines
contractpharma
January 06, 2017
Aims to manufacture oral vaccine formulated to enable stability at 40°C for several weeks.
-
Synthetic Genomics, Janssen Ink RNA Technology Agreement
contractpharma
January 06, 2017
To apply replicon RNA technology for the design and development of medicines for infectious diseases.